|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:ARHGAP44-C17orf78 (FusionGDB2 ID:6121) |
Fusion Gene Summary for ARHGAP44-C17orf78 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ARHGAP44-C17orf78 | Fusion gene ID: 6121 | Hgene | Tgene | Gene symbol | ARHGAP44 | C17orf78 | Gene ID | 9912 | 284099 |
| Gene name | Rho GTPase activating protein 44 | chromosome 17 open reading frame 78 | |
| Synonyms | NPC-A-10|RICH2 | - | |
| Cytomap | 17p12 | 17q12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | rho GTPase-activating protein 44Rho-type GTPase-activating protein RICH2RhoGAP interacting with CIP4 homologs protein 2rho GTPase-activating protein RICH2 | uncharacterized protein C17orf78 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q17R89 | Q8N4C9 | |
| Ensembl transtripts involved in fusion gene | ENST00000262444, ENST00000340825, ENST00000379672, ENST00000578087, | ENST00000300618, ENST00000586700, | |
| Fusion gene scores | * DoF score | 9 X 8 X 6=432 | 4 X 6 X 5=120 |
| # samples | 9 | 5 | |
| ** MAII score | log2(9/432*10)=-2.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/120*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ARHGAP44 [Title/Abstract] AND C17orf78 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | ARHGAP44(12862214)-C17orf78(35746181), # samples:1 ARHGAP44(12862214)-C17orf78(35736075), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | ARHGAP44-C17orf78 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across ARHGAP44 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across C17orf78 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | PRAD | TCGA-V1-A8ML-01A | ARHGAP44 | chr17 | 12862214 | - | C17orf78 | chr17 | 35736075 | + |
| ChimerDB4 | PRAD | TCGA-V1-A8ML-01A | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + |
Top |
Fusion Gene ORF analysis for ARHGAP44-C17orf78 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000262444 | ENST00000300618 | ARHGAP44 | chr17 | 12862214 | - | C17orf78 | chr17 | 35736075 | + |
| Frame-shift | ENST00000262444 | ENST00000300618 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + |
| Frame-shift | ENST00000262444 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | - | C17orf78 | chr17 | 35736075 | + |
| Frame-shift | ENST00000340825 | ENST00000300618 | ARHGAP44 | chr17 | 12862214 | - | C17orf78 | chr17 | 35736075 | + |
| Frame-shift | ENST00000340825 | ENST00000300618 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + |
| Frame-shift | ENST00000340825 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | - | C17orf78 | chr17 | 35736075 | + |
| Frame-shift | ENST00000379672 | ENST00000300618 | ARHGAP44 | chr17 | 12862214 | - | C17orf78 | chr17 | 35736075 | + |
| Frame-shift | ENST00000379672 | ENST00000300618 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + |
| Frame-shift | ENST00000379672 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | - | C17orf78 | chr17 | 35736075 | + |
| In-frame | ENST00000262444 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + |
| In-frame | ENST00000340825 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + |
| In-frame | ENST00000379672 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + |
| intron-3CDS | ENST00000578087 | ENST00000300618 | ARHGAP44 | chr17 | 12862214 | - | C17orf78 | chr17 | 35736075 | + |
| intron-3CDS | ENST00000578087 | ENST00000300618 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + |
| intron-3CDS | ENST00000578087 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | - | C17orf78 | chr17 | 35736075 | + |
| intron-3CDS | ENST00000578087 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000379672 | ARHGAP44 | chr17 | 12862214 | + | ENST00000586700 | C17orf78 | chr17 | 35746181 | + | 3000 | 1823 | 300 | 1835 | 511 |
| ENST00000340825 | ARHGAP44 | chr17 | 12862214 | + | ENST00000586700 | C17orf78 | chr17 | 35746181 | + | 3000 | 1823 | 300 | 1835 | 511 |
| ENST00000262444 | ARHGAP44 | chr17 | 12862214 | + | ENST00000586700 | C17orf78 | chr17 | 35746181 | + | 2779 | 1602 | 79 | 1614 | 511 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000379672 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + | 0.003332287 | 0.9966677 |
| ENST00000340825 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + | 0.003332287 | 0.9966677 |
| ENST00000262444 | ENST00000586700 | ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746181 | + | 0.002972636 | 0.99702734 |
Top |
Fusion Genomic Features for ARHGAP44-C17orf78 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746180 | + | 1.74E-06 | 0.9999982 |
| ARHGAP44 | chr17 | 12862214 | + | C17orf78 | chr17 | 35746180 | + | 1.74E-06 | 0.9999982 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for ARHGAP44-C17orf78 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:12862214/chr17:35746181) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ARHGAP44 | C17orf78 |
| FUNCTION: GTPase-activating protein (GAP) that stimulates the GTPase activity of Rho-type GTPases. Thereby, controls Rho-type GTPases cycling between their active GTP-bound and inactive GDP-bound states. Acts as a GAP at least for CDC42 and RAC1 (PubMed:11431473). In neurons, is involved in dendritic spine formation and synaptic plasticity in a specific RAC1-GAP activity (By similarity). Limits the initiation of exploratory dendritic filopodia. Recruited to actin-patches that seed filopodia, binds specifically to plasma membrane sections that are deformed inward by acto-myosin mediated contractile forces. Acts through GAP activity on RAC1 to reduce actin polymerization necessary for filopodia formation (By similarity). In association with SHANK3, promotes GRIA1 exocytosis from recycling endosomes and spine morphological changes associated to long-term potentiation (By similarity). {ECO:0000250|UniProtKB:F1LQX4, ECO:0000250|UniProtKB:Q5SSM3, ECO:0000269|PubMed:11431473}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ARHGAP44 | chr17:12862214 | chr17:35746181 | ENST00000379672 | + | 16 | 21 | 14_249 | 507 | 819.0 | Domain | BAR |
| Hgene | ARHGAP44 | chr17:12862214 | chr17:35746181 | ENST00000379672 | + | 16 | 21 | 255_445 | 507 | 819.0 | Domain | Rho-GAP |
| Tgene | C17orf78 | chr17:12862214 | chr17:35746181 | ENST00000586700 | 2 | 5 | 187_207 | 130 | 458.3333333333333 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ARHGAP44 | chr17:12862214 | chr17:35746181 | ENST00000379672 | + | 16 | 21 | 815_818 | 507 | 819.0 | Motif | PDZ-binding |
| Tgene | C17orf78 | chr17:12862214 | chr17:35746181 | ENST00000300618 | 4 | 7 | 187_207 | 211 | 276.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for ARHGAP44-C17orf78 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >6121_6121_1_ARHGAP44-C17orf78_ARHGAP44_chr17_12862214_ENST00000262444_C17orf78_chr17_35746181_ENST00000586700_length(transcript)=2779nt_BP=1602nt GAGCCATGTAACCCTGCGGCGGGCTCCGGGCTGCTCCGTCCTTCCCCAGCTCCCGGGCTAGCGCGGCAGCGGGGCCACGATGAAGAAGCA GTTCAATCGCATGCGCCAGCTGGCCAACCAGACGGTGGGCAGGGCTGAAAAGACAGAAGTTTTGAGTGAAGACCTTCTTCAGGTGGAGAA GCGTCTGGAGCTGGTGAAACAGGTGTCCCACAGCACGCACAAGAAGCTCACCGCATGTCTGCAGGGCCAGCAAGGGGCAGAGGCTGACAA GCGCTCCAAAAAGTTGCCTTTGACAACACTGGCTCAGTGTCTGATGGAGGGGTCAGCTATCCTGGGAGATGACACACTTCTTGGGAAGAT GCTGAAACTCTGTGGAGAGACGGAGGACAAGCTGGCTCAGGAGCTGATACATTTTGAGTTGCAAGTAGAGAGAGACGTGATTGAGCCCCT GTTTTTGCTGGCGGAGGTGGAAATCCCAAATATTCAAAAGCAGAGGAAACACTTAGCCAAGTTGGTGCTGGACATGGATTCCTCACGAAC CAGGTGGCAGCAGACTTCCAAGTCTTCAGGTTTGTCCAGCAGCTTACAGCCTGCGGGTGCCAAGGCTGATGCCCTCAGGGAAGAAATGGA AGAGGCTGCCAACAGAGTGGAGATTTGCAGGGACCAGCTCTCAGCTGATATGTACAGTTTTGTGGCCAAAGAAATTGACTATGCAAACTA CTTTCAAACGCTAATAGAAGTGCAAGCTGAATACCACAGGAAGTCCCTGACACTATTGCAGGCTGTATTGCCTCAGATCAAAGCACAACA GGAGGCCTGGGTAGAGAAGCCTTCCTTCGGGAAGCCGCTGGAGGAGCACCTCACCATCAGCGGCCGGGAGATCGCCTTCCCCATCGAGGC GTGTGTGACCATGCTGCTTGAGTGTGGGATGCAGGAGGAGGGACTCTTCCGAGTAGCCCCCTCTGCCTCCAAACTGAAGAAGCTGAAAGC GGCCCTGGACTGCTGCGTGGTGGATGTGCAGGAGTACTCGGCAGACCCCCACGCAATTGCAGGAGCTTTGAAATCTTACCTCCGAGAGTT GCCAGAACCTCTTATGACCTTTGAACTCTATGATGAGTGGATCCAGGCTTCCAATGTCCAGGAGCAAGACAAGAAGCTTCAGGCTCTATG GAATGCTTGTGAAAAGTTGCCCAAGGCCAATCACAACAACATCCGATACTTGATAAAATTTTTATCCAAGCTGTCAGAATATCAAGATGT AAACAAGATGACTCCCAGTAATATGGCAATTGTTTTAGGACCCAACCTCCTATGGCCACAAGCAGAAGGGAACATTACAGAGATGATGAC CACAGTGTCGCTGCAAATTGTTGGGATCATTGAACCTATCATCCAGCATGCAGACTGGTTCTTCCCTGGGGAGATAGAGTTCAACATTAC TGGCAATTATGGGAGTCCAGTACACGTGAACCATAATGCCAACTACAGCTCAATGCCCTCCCCAGACATGGACCCTGCTGACCGGCGCCA GCCCGAGCAGGCCCGCCGGCCCCTCAGCGTCGCCACGGATAATATGATGCTGGAGTTTTACAAAAAGGATGGTATCAATGCCTAGGAGCC AGGAAGCTGTGCCAATGCCAGTGGTTGTGGAGATGGCAAAAGAAGGGAGGCCAGCCACCTGGGACAGCTGAATCCAAGCCTGACTCTCAG CCCCAGAAGGTTGGACAAGATGCTGCCAATTCATCAAACCCAAAGAAAGCTGCAGAGATCACTGTTATCCACCAGACATACTTCTGAAAA GTTCTGCTCTATCTCAAAGACTGAATGATACTACACAGTCCTCTCCCTATTAATATGGGCACATTCTTGCCAATTTCACACTTGTATCTT CAGCAGGGACATTACAATCAAACACCAATTCCTGGTTAATGAAGGGAGAGTGTGGGCTTAGCAGAGTTACCCTCATGCCCCTATCTGAGC CACAACCTTCTGTAATTCACTTCATACATCCATCTAAATGGATACCTTTCCATCCCCTCAAACGAGAACAAAAAGTATTCCCTGCAAGCA CTATGAATGGACCTTACTACTCTCTTTGACAGAAGACTCAAACACAGCCTCTAAGAAACAAGGCAGCTGTTAGTGTGACATAGCTTCCAG CTCCTCTGTTATCTTCACAGCTGACTTCACACTCACTGGCCCTCAATAGCTTAGAGTGGGACTCCTGATCTCCCTGGTTGACGTTTATAA GGTTTTGTAATTTAGCTTCTGGTACTACATGTATCTATCCACACACTGCTGAAGGGAACTTGACCCTACGCATTCCAAAAGCCTTCCTCA TAAGTTATCCCCAAGGGGTTCAGGGACTACAGACCATTAGTACCCAAGTGAAGTCTTCTGACGATCCAGAATTCCTAAGGTGGCTCTGAT ATTATATCATACTTTAATAGAGAGTTGCATACCTTTTGGACAAAGATTCCAGAGCAAAATAATTATGATAATGCTGTTTCTCACAGGAGA ATAGCTATGAGTCAAATCTAACCTGCTTAAATAAGAGTTTGGTGAGAAAGTGAAACCACCTGATCTTGAATCAATGTTGAGGTGAAAAAG GAAATGTCAGGAGGGATAAGACAGGGTGAGGCCCTGCTTCTTTTCCTAAGAGTCTGAAACCATTCCATTTCATTTTGGTGAAATGTGTCT >6121_6121_1_ARHGAP44-C17orf78_ARHGAP44_chr17_12862214_ENST00000262444_C17orf78_chr17_35746181_ENST00000586700_length(amino acids)=511AA_BP= MKKQFNRMRQLANQTVGRAEKTEVLSEDLLQVEKRLELVKQVSHSTHKKLTACLQGQQGAEADKRSKKLPLTTLAQCLMEGSAILGDDTL LGKMLKLCGETEDKLAQELIHFELQVERDVIEPLFLLAEVEIPNIQKQRKHLAKLVLDMDSSRTRWQQTSKSSGLSSSLQPAGAKADALR EEMEEAANRVEICRDQLSADMYSFVAKEIDYANYFQTLIEVQAEYHRKSLTLLQAVLPQIKAQQEAWVEKPSFGKPLEEHLTISGREIAF PIEACVTMLLECGMQEEGLFRVAPSASKLKKLKAALDCCVVDVQEYSADPHAIAGALKSYLRELPEPLMTFELYDEWIQASNVQEQDKKL QALWNACEKLPKANHNNIRYLIKFLSKLSEYQDVNKMTPSNMAIVLGPNLLWPQAEGNITEMMTTVSLQIVGIIEPIIQHADWFFPGEIE -------------------------------------------------------------- >6121_6121_2_ARHGAP44-C17orf78_ARHGAP44_chr17_12862214_ENST00000340825_C17orf78_chr17_35746181_ENST00000586700_length(transcript)=3000nt_BP=1823nt GACTGGGAGCAGGCAGCCCGGGCGGAGCGGGCCGGTGCCGAGGACGGCCCCAGGCATTGCTCTGCCCCGGGCATTGCGCGGCGCGCGTGA GGGGGATGCGGCAGGAGGCGGCGCGGCGGGAGGAGTAGGCGGCGGCGCCCTCGGGAGGGAGCTGCGCGCGGGCCAGACGGCGCCCGGAGG CTCCGCAGTGCCGCCGCCGTCGCCCGGGAGGCTCCGCGCGGGAGCCATGTAACCCTGCGGCGGGCTCCGGGCTGCTCCGTCCTTCCCCAG CTCCCGGGCTAGCGCGGCAGCGGGGCCACGATGAAGAAGCAGTTCAATCGCATGCGCCAGCTGGCCAACCAGACGGTGGGCAGGGCTGAA AAGACAGAAGTTTTGAGTGAAGACCTTCTTCAGGTGGAGAAGCGTCTGGAGCTGGTGAAACAGGTGTCCCACAGCACGCACAAGAAGCTC ACCGCATGTCTGCAGGGCCAGCAAGGGGCAGAGGCTGACAAGCGCTCCAAAAAGTTGCCTTTGACAACACTGGCTCAGTGTCTGATGGAG GGGTCAGCTATCCTGGGAGATGACACACTTCTTGGGAAGATGCTGAAACTCTGTGGAGAGACGGAGGACAAGCTGGCTCAGGAGCTGATA CATTTTGAGTTGCAAGTAGAGAGAGACGTGATTGAGCCCCTGTTTTTGCTGGCGGAGGTGGAAATCCCAAATATTCAAAAGCAGAGGAAA CACTTAGCCAAGTTGGTGCTGGACATGGATTCCTCACGAACCAGGTGGCAGCAGACTTCCAAGTCTTCAGGTTTGTCCAGCAGCTTACAG CCTGCGGGTGCCAAGGCTGATGCCCTCAGGGAAGAAATGGAAGAGGCTGCCAACAGAGTGGAGATTTGCAGGGACCAGCTCTCAGCTGAT ATGTACAGTTTTGTGGCCAAAGAAATTGACTATGCAAACTACTTTCAAACGCTAATAGAAGTGCAAGCTGAATACCACAGGAAGTCCCTG ACACTATTGCAGGCTGTATTGCCTCAGATCAAAGCACAACAGGAGGCCTGGGTAGAGAAGCCTTCCTTCGGGAAGCCGCTGGAGGAGCAC CTCACCATCAGCGGCCGGGAGATCGCCTTCCCCATCGAGGCGTGTGTGACCATGCTGCTTGAGTGTGGGATGCAGGAGGAGGGACTCTTC CGAGTAGCCCCCTCTGCCTCCAAACTGAAGAAGCTGAAAGCGGCCCTGGACTGCTGCGTGGTGGATGTGCAGGAGTACTCGGCAGACCCC CACGCAATTGCAGGAGCTTTGAAATCTTACCTCCGAGAGTTGCCAGAACCTCTTATGACCTTTGAACTCTATGATGAGTGGATCCAGGCT TCCAATGTCCAGGAGCAAGACAAGAAGCTTCAGGCTCTATGGAATGCTTGTGAAAAGTTGCCCAAGGCCAATCACAACAACATCCGATAC TTGATAAAATTTTTATCCAAGCTGTCAGAATATCAAGATGTAAACAAGATGACTCCCAGTAATATGGCAATTGTTTTAGGACCCAACCTC CTATGGCCACAAGCAGAAGGGAACATTACAGAGATGATGACCACAGTGTCGCTGCAAATTGTTGGGATCATTGAACCTATCATCCAGCAT GCAGACTGGTTCTTCCCTGGGGAGATAGAGTTCAACATTACTGGCAATTATGGGAGTCCAGTACACGTGAACCATAATGCCAACTACAGC TCAATGCCCTCCCCAGACATGGACCCTGCTGACCGGCGCCAGCCCGAGCAGGCCCGCCGGCCCCTCAGCGTCGCCACGGATAATATGATG CTGGAGTTTTACAAAAAGGATGGTATCAATGCCTAGGAGCCAGGAAGCTGTGCCAATGCCAGTGGTTGTGGAGATGGCAAAAGAAGGGAG GCCAGCCACCTGGGACAGCTGAATCCAAGCCTGACTCTCAGCCCCAGAAGGTTGGACAAGATGCTGCCAATTCATCAAACCCAAAGAAAG CTGCAGAGATCACTGTTATCCACCAGACATACTTCTGAAAAGTTCTGCTCTATCTCAAAGACTGAATGATACTACACAGTCCTCTCCCTA TTAATATGGGCACATTCTTGCCAATTTCACACTTGTATCTTCAGCAGGGACATTACAATCAAACACCAATTCCTGGTTAATGAAGGGAGA GTGTGGGCTTAGCAGAGTTACCCTCATGCCCCTATCTGAGCCACAACCTTCTGTAATTCACTTCATACATCCATCTAAATGGATACCTTT CCATCCCCTCAAACGAGAACAAAAAGTATTCCCTGCAAGCACTATGAATGGACCTTACTACTCTCTTTGACAGAAGACTCAAACACAGCC TCTAAGAAACAAGGCAGCTGTTAGTGTGACATAGCTTCCAGCTCCTCTGTTATCTTCACAGCTGACTTCACACTCACTGGCCCTCAATAG CTTAGAGTGGGACTCCTGATCTCCCTGGTTGACGTTTATAAGGTTTTGTAATTTAGCTTCTGGTACTACATGTATCTATCCACACACTGC TGAAGGGAACTTGACCCTACGCATTCCAAAAGCCTTCCTCATAAGTTATCCCCAAGGGGTTCAGGGACTACAGACCATTAGTACCCAAGT GAAGTCTTCTGACGATCCAGAATTCCTAAGGTGGCTCTGATATTATATCATACTTTAATAGAGAGTTGCATACCTTTTGGACAAAGATTC CAGAGCAAAATAATTATGATAATGCTGTTTCTCACAGGAGAATAGCTATGAGTCAAATCTAACCTGCTTAAATAAGAGTTTGGTGAGAAA GTGAAACCACCTGATCTTGAATCAATGTTGAGGTGAAAAAGGAAATGTCAGGAGGGATAAGACAGGGTGAGGCCCTGCTTCTTTTCCTAA GAGTCTGAAACCATTCCATTTCATTTTGGTGAAATGTGTCTGTTTCTAAGAAATTCTGTTTTCTTAGTTCTCTGGTTAAAAAAAAAAATA >6121_6121_2_ARHGAP44-C17orf78_ARHGAP44_chr17_12862214_ENST00000340825_C17orf78_chr17_35746181_ENST00000586700_length(amino acids)=511AA_BP= MKKQFNRMRQLANQTVGRAEKTEVLSEDLLQVEKRLELVKQVSHSTHKKLTACLQGQQGAEADKRSKKLPLTTLAQCLMEGSAILGDDTL LGKMLKLCGETEDKLAQELIHFELQVERDVIEPLFLLAEVEIPNIQKQRKHLAKLVLDMDSSRTRWQQTSKSSGLSSSLQPAGAKADALR EEMEEAANRVEICRDQLSADMYSFVAKEIDYANYFQTLIEVQAEYHRKSLTLLQAVLPQIKAQQEAWVEKPSFGKPLEEHLTISGREIAF PIEACVTMLLECGMQEEGLFRVAPSASKLKKLKAALDCCVVDVQEYSADPHAIAGALKSYLRELPEPLMTFELYDEWIQASNVQEQDKKL QALWNACEKLPKANHNNIRYLIKFLSKLSEYQDVNKMTPSNMAIVLGPNLLWPQAEGNITEMMTTVSLQIVGIIEPIIQHADWFFPGEIE -------------------------------------------------------------- >6121_6121_3_ARHGAP44-C17orf78_ARHGAP44_chr17_12862214_ENST00000379672_C17orf78_chr17_35746181_ENST00000586700_length(transcript)=3000nt_BP=1823nt GACTGGGAGCAGGCAGCCCGGGCGGAGCGGGCCGGTGCCGAGGACGGCCCCAGGCATTGCTCTGCCCCGGGCATTGCGCGGCGCGCGTGA GGGGGATGCGGCAGGAGGCGGCGCGGCGGGAGGAGTAGGCGGCGGCGCCCTCGGGAGGGAGCTGCGCGCGGGCCAGACGGCGCCCGGAGG CTCCGCAGTGCCGCCGCCGTCGCCCGGGAGGCTCCGCGCGGGAGCCATGTAACCCTGCGGCGGGCTCCGGGCTGCTCCGTCCTTCCCCAG CTCCCGGGCTAGCGCGGCAGCGGGGCCACGATGAAGAAGCAGTTCAATCGCATGCGCCAGCTGGCCAACCAGACGGTGGGCAGGGCTGAA AAGACAGAAGTTTTGAGTGAAGACCTTCTTCAGGTGGAGAAGCGTCTGGAGCTGGTGAAACAGGTGTCCCACAGCACGCACAAGAAGCTC ACCGCATGTCTGCAGGGCCAGCAAGGGGCAGAGGCTGACAAGCGCTCCAAAAAGTTGCCTTTGACAACACTGGCTCAGTGTCTGATGGAG GGGTCAGCTATCCTGGGAGATGACACACTTCTTGGGAAGATGCTGAAACTCTGTGGAGAGACGGAGGACAAGCTGGCTCAGGAGCTGATA CATTTTGAGTTGCAAGTAGAGAGAGACGTGATTGAGCCCCTGTTTTTGCTGGCGGAGGTGGAAATCCCAAATATTCAAAAGCAGAGGAAA CACTTAGCCAAGTTGGTGCTGGACATGGATTCCTCACGAACCAGGTGGCAGCAGACTTCCAAGTCTTCAGGTTTGTCCAGCAGCTTACAG CCTGCGGGTGCCAAGGCTGATGCCCTCAGGGAAGAAATGGAAGAGGCTGCCAACAGAGTGGAGATTTGCAGGGACCAGCTCTCAGCTGAT ATGTACAGTTTTGTGGCCAAAGAAATTGACTATGCAAACTACTTTCAAACGCTAATAGAAGTGCAAGCTGAATACCACAGGAAGTCCCTG ACACTATTGCAGGCTGTATTGCCTCAGATCAAAGCACAACAGGAGGCCTGGGTAGAGAAGCCTTCCTTCGGGAAGCCGCTGGAGGAGCAC CTCACCATCAGCGGCCGGGAGATCGCCTTCCCCATCGAGGCGTGTGTGACCATGCTGCTTGAGTGTGGGATGCAGGAGGAGGGACTCTTC CGAGTAGCCCCCTCTGCCTCCAAACTGAAGAAGCTGAAAGCGGCCCTGGACTGCTGCGTGGTGGATGTGCAGGAGTACTCGGCAGACCCC CACGCAATTGCAGGAGCTTTGAAATCTTACCTCCGAGAGTTGCCAGAACCTCTTATGACCTTTGAACTCTATGATGAGTGGATCCAGGCT TCCAATGTCCAGGAGCAAGACAAGAAGCTTCAGGCTCTATGGAATGCTTGTGAAAAGTTGCCCAAGGCCAATCACAACAACATCCGATAC TTGATAAAATTTTTATCCAAGCTGTCAGAATATCAAGATGTAAACAAGATGACTCCCAGTAATATGGCAATTGTTTTAGGACCCAACCTC CTATGGCCACAAGCAGAAGGGAACATTACAGAGATGATGACCACAGTGTCGCTGCAAATTGTTGGGATCATTGAACCTATCATCCAGCAT GCAGACTGGTTCTTCCCTGGGGAGATAGAGTTCAACATTACTGGCAATTATGGGAGTCCAGTACACGTGAACCATAATGCCAACTACAGC TCAATGCCCTCCCCAGACATGGACCCTGCTGACCGGCGCCAGCCCGAGCAGGCCCGCCGGCCCCTCAGCGTCGCCACGGATAATATGATG CTGGAGTTTTACAAAAAGGATGGTATCAATGCCTAGGAGCCAGGAAGCTGTGCCAATGCCAGTGGTTGTGGAGATGGCAAAAGAAGGGAG GCCAGCCACCTGGGACAGCTGAATCCAAGCCTGACTCTCAGCCCCAGAAGGTTGGACAAGATGCTGCCAATTCATCAAACCCAAAGAAAG CTGCAGAGATCACTGTTATCCACCAGACATACTTCTGAAAAGTTCTGCTCTATCTCAAAGACTGAATGATACTACACAGTCCTCTCCCTA TTAATATGGGCACATTCTTGCCAATTTCACACTTGTATCTTCAGCAGGGACATTACAATCAAACACCAATTCCTGGTTAATGAAGGGAGA GTGTGGGCTTAGCAGAGTTACCCTCATGCCCCTATCTGAGCCACAACCTTCTGTAATTCACTTCATACATCCATCTAAATGGATACCTTT CCATCCCCTCAAACGAGAACAAAAAGTATTCCCTGCAAGCACTATGAATGGACCTTACTACTCTCTTTGACAGAAGACTCAAACACAGCC TCTAAGAAACAAGGCAGCTGTTAGTGTGACATAGCTTCCAGCTCCTCTGTTATCTTCACAGCTGACTTCACACTCACTGGCCCTCAATAG CTTAGAGTGGGACTCCTGATCTCCCTGGTTGACGTTTATAAGGTTTTGTAATTTAGCTTCTGGTACTACATGTATCTATCCACACACTGC TGAAGGGAACTTGACCCTACGCATTCCAAAAGCCTTCCTCATAAGTTATCCCCAAGGGGTTCAGGGACTACAGACCATTAGTACCCAAGT GAAGTCTTCTGACGATCCAGAATTCCTAAGGTGGCTCTGATATTATATCATACTTTAATAGAGAGTTGCATACCTTTTGGACAAAGATTC CAGAGCAAAATAATTATGATAATGCTGTTTCTCACAGGAGAATAGCTATGAGTCAAATCTAACCTGCTTAAATAAGAGTTTGGTGAGAAA GTGAAACCACCTGATCTTGAATCAATGTTGAGGTGAAAAAGGAAATGTCAGGAGGGATAAGACAGGGTGAGGCCCTGCTTCTTTTCCTAA GAGTCTGAAACCATTCCATTTCATTTTGGTGAAATGTGTCTGTTTCTAAGAAATTCTGTTTTCTTAGTTCTCTGGTTAAAAAAAAAAATA >6121_6121_3_ARHGAP44-C17orf78_ARHGAP44_chr17_12862214_ENST00000379672_C17orf78_chr17_35746181_ENST00000586700_length(amino acids)=511AA_BP= MKKQFNRMRQLANQTVGRAEKTEVLSEDLLQVEKRLELVKQVSHSTHKKLTACLQGQQGAEADKRSKKLPLTTLAQCLMEGSAILGDDTL LGKMLKLCGETEDKLAQELIHFELQVERDVIEPLFLLAEVEIPNIQKQRKHLAKLVLDMDSSRTRWQQTSKSSGLSSSLQPAGAKADALR EEMEEAANRVEICRDQLSADMYSFVAKEIDYANYFQTLIEVQAEYHRKSLTLLQAVLPQIKAQQEAWVEKPSFGKPLEEHLTISGREIAF PIEACVTMLLECGMQEEGLFRVAPSASKLKKLKAALDCCVVDVQEYSADPHAIAGALKSYLRELPEPLMTFELYDEWIQASNVQEQDKKL QALWNACEKLPKANHNNIRYLIKFLSKLSEYQDVNKMTPSNMAIVLGPNLLWPQAEGNITEMMTTVSLQIVGIIEPIIQHADWFFPGEIE -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ARHGAP44-C17orf78 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | ARHGAP44 | chr17:12862214 | chr17:35746181 | ENST00000379672 | + | 16 | 21 | 731_818 | 507.6666666666667 | 819.0 | BST2 |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ARHGAP44-C17orf78 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ARHGAP44-C17orf78 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies